---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-024738"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:13:48.342758+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Hepion raises $2.06M via warrant inducement, reduces exercise prices and issues new warrants

## Summary
- Holders of 980,393 Series B warrants will exercise at reduced price of $2.10/share, raising ~$2.06M gross proceeds.
- As inducement, Company reduces Series A warrant exercise price to $1.91 (from $4.85) and extends expiration to Feb 2029.
- Company issues new Series B-1 and B-2 warrants to purchase up to 735,295 shares each at $1.91.
- Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee of 7% of gross proceeds.
- Net proceeds to be used for general working capital and corporate purposes.

## SEC filing metadata
- accession: 0001104659-24-024738
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000110465924024738/0001104659-24-024738-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000110465924024738/tm246503d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-024738
- JSON: https://secwatch.observer/filing/0001104659-24-024738.json
- Plain text: https://secwatch.observer/filing/0001104659-24-024738.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.